Prospective Cohort of Patients With Intracerebral Hemorrhage
Trial Parameters
Brief Summary
The investigators designed a multicentral, observational, prospective cohort study to provide cortical data for risk stratification and biomarkers on early outcomes, complications, long-term neurological function, and cognitive status of spontaneous intracerebral hemorrhage patients.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with spontaneous intracerebral hemorrhage (ICH) through skull radiologic scans (CT or MRI); * Underwent no surgical intervention; Exclusion Criteria: * Secondary intracerebral hemorrhage (with leading cause, e.g., Moyamoya disease, arteriovenous malformation, intracranial aneurysm, tumor, brain trauma) * Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis) * Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease) * Unsuitable for inclusion in the study in the opinion of the investigator